Acute Myeloid Leukemia Treatment in India
About Acute Myeloid Leukemia
Key Highlights
-
Comprehensive, personalized treatment plan designed by a specialist in blood cancers.Utilizes advanced chemotherapy protocols to rapidly target and reduce leukemia cells.Potential for curative intent, especially in younger, fit patients.Access to cutting-edge treatments like targeted therapy and stem cell transplantation.Integrated, multidisciplinary care involving transfusion support, infection management, and nutritional counseling.
Who is this surgery for?
- Confirmed diagnosis of Acute Myeloid Leukemia via bone marrow biopsy and genetic testing.
- Presence of symptoms like fatigue, frequent infections, easy bruising/bleeding, or unexplained fever.
- High white blood cell (blast) count in peripheral blood.
- As a first-line treatment for newly diagnosed patients to achieve remission.
- For treatment of relapsed or refractory AML after previous therapy.
How to prepare
- Comprehensive diagnostic workup: Complete blood count (CBC), bone marrow aspiration/biopsy, and cytogenetic/molecular testing.
- Pre-treatment assessments: Heart (ECHO/ECG), lung, kidney, and liver function tests.
- Consultation with the Hemato-Oncologist to discuss the treatment plan, phases, and potential side effects.
- Dental check-up to prevent infections during immunosuppression.
- Fertility preservation counseling (e.g., sperm/egg banking) if applicable.
- Arranging for a central venous catheter (e.g., PICC line) placement for chemotherapy administration.
Risks & possible complications
- Severe bone marrow suppression leading to infection, anemia, and bleeding risks.
- Chemotherapy side effects: nausea, mouth sores, hair loss, and fatigue.
- Potential damage to organs like the heart, liver, or kidneys.
- High risk of life-threatening infections during periods of low immunity (neutropenia).
- Complications specific to stem cell transplant, including graft-versus-host disease (GVHD) and graft failure.
- Long-term risks of secondary cancers or infertility.
Recovery & hospital stay
- Initial recovery from induction chemotherapy occurs in the hospital over 4-6 weeks, focusing on managing side effects and waiting for blood counts to recover.
- Frequent follow-up visits for blood tests and monitoring for signs of infection or relapse.
- Consolidation chemotherapy or transplant may require additional prolonged hospital stays.
- Post-discharge care includes strict hygiene, avoiding crowds, and a neutropenic diet to prevent infection.
- Long-term follow-up with the Hemato-Oncologist for surveillance, managing late effects, and psychological support.
-
Typical hospital stay:
4-8 weeks (per treatment phase)
-
Expected recovery time:
6-12 months (for full recovery post-treatment)
Frequently Asked Questions
If you are considering acute myeloid leukemia in India, these questions and answers can help you make a confident, informed decision.
Top-rated hospitals in India with hemato oncology departments and experienced surgeons are ideal for this procedure. Use MediFyr to compare facilities, reviews, and doctor profiles before you decide.
Look at the doctor’s years of experience, hospital association, patient reviews, and how often they perform acute myeloid leukemia. MediFyr helps you compare hemato oncologists and book consultations online.
The overall cost depends on hospital category, surgeon’s experience, room type, implant or device used (if any), length of stay, tests, and post-operative care. Our team can help you get cost estimates from multiple hospitals before you decide.
Procedure cost in other countries
Here is an overview of how the estimated cost, hospital stay, and recovery time for acute myeloid leukemia compare across other countries where we have data.
| Country | Estimated cost range | Typical stay | Recovery time | View details |
|---|---|---|---|---|
| India | INR 800 Thousand – 5 Million | 4-8 weeks (per treatment phase) | ~ 6-12 months (for full recovery post-treatment) | Know More |
| Turkey | TRY 2.8 Million – 17.5 Million | 4-8 weeks (per treatment phase) | ~ 6-12 months (for full recovery post-treatment) | Know More |
Neha Iyer, a 28-year-old ambitious software...
Neha Iyer, a 28-year-old ambitious software engineer, had just moved to a new city for her dream job. For weeks, she dismissed her extreme fatigue as stress from the relocation and long work hours. When she developed persistent fever, unexplained bruises on her legs, and frequent nosebleeds, she finally visited her GP. Blood tests revealed alarming abnormalities, leading to an urgent referral to a hemato-oncologist, Dr. Mehta. A bone marrow biopsy confirmed the devastating diagnosis: Acute Myeloid Leukemia (AML). Dr. Mehta recommended immediate induction chemotherapy, an intensive 7-day inpatient regimen to achieve remission. Neha's treatment was grueling; she experienced severe nausea, mouth sores, and profound weakness, isolated in a sterile room. After a tense wait, her post-treatment bone marrow showed complete morphological remission. Emotionally, Neha was initially shattered, grieving her derailed career and independence. The support of her family, who moved to be with her, and a hospital support group became her anchors. Achieving remission filled her with cautious hope and a fierce determination to fight through the consolidation therapy ahead, reshaping her perspective on life's fragility and strength.
Hemato Oncologists for Acute Myeloid Leukemia
Explore experienced hemato oncologists who regularly perform acute myeloid leukemia and provide pre- and post-operative care in India.
- 13 Years Experience
- Hemato Oncologist
Kamineni Hospital LB Nagar, Hyderabad
- 10 Years Experience
- Hemato Oncologist
Manipal Hospital Mukundapur, Kolkata